本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ligand Pharmaceuticals Inc.

108.07
-0.4800-0.44%
盘后108.070.00000.00%19:41 EDT
成交量:10.30万
成交额:1,099.52万
市值:20.81亿
市盈率:-490.23
高:108.34
开:106.95
低:104.65
收:108.55
数据加载中...
2025/04/17

重要事件披露

Form 8-K - Current report
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/25

重要事件披露

Form 8-K - Current report
2024/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/01

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]